PERSPECTA

News from every angle

← Back to headlines

GLP-1 Drugs' Cold Chain Requirement Boosts UPS and FedEx Growth

The necessity for GLP-1 drugs to remain cold is emerging as a significant growth driver for logistics giants United Parcel Service, Inc. (UPS) and FedEx Corporation (FDX). This requirement creates new opportunities in cold chain logistics.

27 Jul, 19:03 — 27 Jul, 19:03
PostShare

Sources

Showing 1 of 1 sources
YahooMostly Factual21d ago

GLP-1 Drugs Need to Stay Cold: Is it Turning Into a Real Growth Story for United Parcel Service, Inc. (UPS) and FedEx Corporation (FDX)?

Read full article →

Related Stories

Paramount Seeks $1.88 Billion Bond from State AGs for WBD Merger Delay

39m ago

Greece Reports €5.7 Billion Primary Surplus for January-July 2026

54m ago

Diana Shipping Withdraws Bid to Acquire Genco, Shares Surge

58m ago

SC Asks SIT to Expedite Ram Temple Donations Row Probe

1h ago